国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2009年
6期
551-554
,共4页
黄烈%林广城%张银辉%夏成静%刘键%张海燕%陆学东
黃烈%林廣城%張銀輝%夏成靜%劉鍵%張海燕%陸學東
황렬%림엄성%장은휘%하성정%류건%장해연%륙학동
葡萄球菌属%大环内酯类%抗菌药%基因
葡萄毬菌屬%大環內酯類%抗菌藥%基因
포도구균속%대배내지류%항균약%기인
Staphylococcus%Macrolides%Anti bacterial agents%Genes
目的 了解葡萄球菌对大环内酯类抗生素生物耐药表型与基因型的符合情况,分析耐药基因检出与生物耐药诱导的关系,并预测细菌耐药流行趋势,从基因水平指导临床合理用药.方法 用KB纸片法检测本院2004~2005年分离的136株葡萄球菌对红霉素和克林霉素的耐药性,以聚合酶链反应(PCR)法榆测葡萄球菌MsrA、vgb、Sat4、ermA、ermB、ermC、mphA、MefA/E、ereA、ereB 10种耐药基因,并将其耐药表型与基因型进行比较.将对红霉素表型敏感而耐药基因阳性的菌株进行诱导,对比诱导前后药敏结果.结果 136株葡萄球菌对红霉素耐药的占80.88%,对红霉素和克林霉素同时耐药占43.38%,结果表明葡萄球菌对大环内酯类有较高的耐药率.耐药基因检测结果表明,共检出MsrA、Sat4、ermA、ermB、ermC、mphA、ereB 7种耐药基因,耐药基因检出率为83.82%.其中核糖体甲基化酶基因ermC的阳性率最高,占检测基因的67.54%;其次为Sat4、MsrA、ereB、ermA、ermB、mphA,分别占50.00%、28.95%、22.81%、15.80%、9.65%、1.75%.MRSA、MRCNS、MSSA、MSCNS菌株耐药基因的检出率分别为100.00%,90.78%、73.08%、55.55%.11株对红霉素敏感而耐药基因阳性的菌株经红霉素诱导后有9株转为耐药,诱导阳性率为81.82%.结论 葡萄球菌对大环内酯类抗生素有较高的耐药性,在部分敏感株中检测出耐药基因,经诱导可产生耐药,提示菌株有潜在耐药性,需特别引起临床的重视.临床微生物实验室应同时开展表型及基因型检测,指导临床更加合理使用抗生素.
目的 瞭解葡萄毬菌對大環內酯類抗生素生物耐藥錶型與基因型的符閤情況,分析耐藥基因檢齣與生物耐藥誘導的關繫,併預測細菌耐藥流行趨勢,從基因水平指導臨床閤理用藥.方法 用KB紙片法檢測本院2004~2005年分離的136株葡萄毬菌對紅黴素和剋林黴素的耐藥性,以聚閤酶鏈反應(PCR)法榆測葡萄毬菌MsrA、vgb、Sat4、ermA、ermB、ermC、mphA、MefA/E、ereA、ereB 10種耐藥基因,併將其耐藥錶型與基因型進行比較.將對紅黴素錶型敏感而耐藥基因暘性的菌株進行誘導,對比誘導前後藥敏結果.結果 136株葡萄毬菌對紅黴素耐藥的佔80.88%,對紅黴素和剋林黴素同時耐藥佔43.38%,結果錶明葡萄毬菌對大環內酯類有較高的耐藥率.耐藥基因檢測結果錶明,共檢齣MsrA、Sat4、ermA、ermB、ermC、mphA、ereB 7種耐藥基因,耐藥基因檢齣率為83.82%.其中覈糖體甲基化酶基因ermC的暘性率最高,佔檢測基因的67.54%;其次為Sat4、MsrA、ereB、ermA、ermB、mphA,分彆佔50.00%、28.95%、22.81%、15.80%、9.65%、1.75%.MRSA、MRCNS、MSSA、MSCNS菌株耐藥基因的檢齣率分彆為100.00%,90.78%、73.08%、55.55%.11株對紅黴素敏感而耐藥基因暘性的菌株經紅黴素誘導後有9株轉為耐藥,誘導暘性率為81.82%.結論 葡萄毬菌對大環內酯類抗生素有較高的耐藥性,在部分敏感株中檢測齣耐藥基因,經誘導可產生耐藥,提示菌株有潛在耐藥性,需特彆引起臨床的重視.臨床微生物實驗室應同時開展錶型及基因型檢測,指導臨床更加閤理使用抗生素.
목적 료해포도구균대대배내지류항생소생물내약표형여기인형적부합정황,분석내약기인검출여생물내약유도적관계,병예측세균내약류행추세,종기인수평지도림상합리용약.방법 용KB지편법검측본원2004~2005년분리적136주포도구균대홍매소화극림매소적내약성,이취합매련반응(PCR)법유측포도구균MsrA、vgb、Sat4、ermA、ermB、ermC、mphA、MefA/E、ereA、ereB 10충내약기인,병장기내약표형여기인형진행비교.장대홍매소표형민감이내약기인양성적균주진행유도,대비유도전후약민결과.결과 136주포도구균대홍매소내약적점80.88%,대홍매소화극림매소동시내약점43.38%,결과표명포도구균대대배내지류유교고적내약솔.내약기인검측결과표명,공검출MsrA、Sat4、ermA、ermB、ermC、mphA、ereB 7충내약기인,내약기인검출솔위83.82%.기중핵당체갑기화매기인ermC적양성솔최고,점검측기인적67.54%;기차위Sat4、MsrA、ereB、ermA、ermB、mphA,분별점50.00%、28.95%、22.81%、15.80%、9.65%、1.75%.MRSA、MRCNS、MSSA、MSCNS균주내약기인적검출솔분별위100.00%,90.78%、73.08%、55.55%.11주대홍매소민감이내약기인양성적균주경홍매소유도후유9주전위내약,유도양성솔위81.82%.결론 포도구균대대배내지류항생소유교고적내약성,재부분민감주중검측출내약기인,경유도가산생내약,제시균주유잠재내약성,수특별인기림상적중시.림상미생물실험실응동시개전표형급기인형검측,지도림상경가합리사용항생소.
Objective To investigate the coincidence between the phenotype and genotype of macrolides resistance in staphylococci,analyze the relationship between resistance gene and induced resistance,forecast the bacterial resistance tendency,and to provide a reasonable drug use guide for clinic at gene level.Methods Disk diffusion method was used to test the erythromycin and clindamycin resistance phenotype of 136 isolates of staphylococci in our hospital from 2004 to 2005.Ten genes such as MsrA,vgb,Sat4,armA,ermB,ermC,mphA,MefA/E,ereA and ereB were detected by applying polymerase chain reaction(PCR),and the strains of negative phenotype and positive genotype were induced.Results 80.88% of staphylococcus isolates was resistant to erythromycin,and 43.38% was resistance to both erythromycin and clindamycin.The results showed that staphylococcus was highly resistant to macrolides.Seven genes were detected,i.e.MsrA,Sat4,ermA,ermB,ermC,mphA and ereB.The detection rate of resistance genes was 83.82%,in which erythromycin ribosome methylase gene ermC was the highest(67.54%),followed by Sat4(50.00%),MsrA(28.95%),ereB(22.81%),ermA(15.80%),ermB(9.65%)and mphA(1.75%).The detection rate of resistance genes of MRSA,MRCNS,MSSA and MSCNS strains was 100.00%,90.78%,73.08% and 55.55% respectively.A total of 11 strains with resistance gene positive were sensitive to erythromycin,but after erythromycin induction,9 strains(81.82%)became resistant to erythromycin.Conclusion Staphylococcus exhibits high resistance to macrolides.Drug resistance gene can be detected in some sensitive strains,indicating these strains may posses potential drug resistance.Therefore,the drug resistance of surveillance must be strengened,and we must emphasize on reasonable option of antimicrobial agents in clinical therapy in our area.